ResearcherShandong UniversityActive in the last 2 years
Yingkun Xu
Matched on ORCID iD 0000-0002-0100-9117; OpenAlex author ID A5050991729. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: none · 2024: 1 paper
Papers 2
- Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancer. First author DOI 10.21037/tcr-24-505↗
- Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients. Co-author DOI 10.1155/2022/2363043↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shengchun Liu · 2 shared papers, 2022–2024 · strength 0.38
- Dongyao Pu · 1 shared paper, 2024 · strength 0.23
- Haochen Yu · 1 shared paper, 2024 · strength 0.23
- Xin Liu · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.